The DOI matches its Crossref record; 233 of the 233 references it cites were found in a registry or an index.
The corticostriatal pathway in Huntington's disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Exercise: a behavioral intervention to enhance brain health and plasticity
Cotman, C. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02143-4 · Cited by 2,739
Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., & Aronin, N. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,439
Neuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227
Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., & Bates, G. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80513-9 · Cited by 2,181
A gene expression atlas of the central nervous system based on bacterial artificial chromosomes
Gong, S., Zheng, C., Doughty, M. L., Losos, K., Didkovsky, N., Schambra, U. B., Nowak, N. J., Joyner, A., Leblanc, G., Hatten, M. E., et al. (2003) · Nature · doi:10.1038/nature02033 · Cited by 2,108
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686
The neostriatal mosaic: multiple levels of compartmental organization
Gerfen, C. R. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90355-c · Cited by 1,467
G. Vonsattel, J. P., & DiFiglia, M. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199805000-00001 · Cited by 1,306
Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid
Beal, M. F., Kowall, N. W., Ellison, D. W., Mazurek, M. F., Swartz, K. J., & Martin, J. B. (1986) · Nature · doi:10.1038/321168a0 · Cited by 1,286
Striatal interneurones: chemical, physiological and morphological characterization
Kawaguchi, Y., Wilson, C. J., Augood, S. J., & Emson, P. C. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)98374-8 · Cited by 1,198
Gauthier, L. R., Charrin, B. C., Borrell-Pagès, M., Dompierre, J. P., Rangone, H., Cordelières, F. P., De Mey, J., MacDonald, M. E., Leßmann, V., Humbert, S., et al. (2004) · Cell · doi:10.1016/j.cell.2004.06.018 · Cited by 1,178
Cellular localization of brain monoamines.
Carlsson, A. C., FALCK, B., & Hillarp, N. ‐. (1962) · PubMed · Cited by 1,161
Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease
Zuccato, C., Ciammola, A., Rigamonti, D., Leavitt, B. R., Goffredo, D., Conti, L., MacDonald, M. E., Friedlander, R. M., Silani, V., Hayden, M. R., et al. (2001) · Science · doi:10.1126/science.1059581 · Cited by 1,123
Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease
Yamamoto, A., Lucas, J. J., & Hen, R. (2000) · Cell · doi:10.1016/s0092-8674(00)80623-6 · Cited by 1,067
Regional and progressive thinning of the cortical ribbon in Huntington’s disease
Rosas, H. D., Liu, A. K., Hersch, S., Glessner, M., Ferrante, R. J., Salat, D. H., van der Kouwe, A., Jenkins, B. G., Dale, A. M., & Fischl, B. (2002) · Neurology · doi:10.1212/wnl.58.5.695 · Cited by 1,044
David Smith, A., & Paul Bolam, J. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90106-k · Cited by 1,036
Carter, R. J., Lione, L. A., Humby, T., Mangiarini, L., Mahal, A., Bates, G. P., Dunnett, S. B., & Morton, A. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-08-03248.1999 · Cited by 947
(1998) · Neuroscience · doi:10.1016/s0306-4522(98)00004-9 · Cited by 941
Nuclear and Neuropil Aggregates in Huntington’s Disease: Relationship to Neuropathology
Gutekunst, C.-A., Li, S.-H., Yi, H., Mulroy, J. S., Kuemmerle, S., Jones, R., Rye, D., Ferrante, R. J., Hersch, S. M., & Li, X.-J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02522.1999 · Cited by 914 · cited 1×
“Neuropil aggregates appear to be more common than nuclear aggregates and are more prevalent in cortex than in striatum (Gutekunst et al., 1999).”
BackgroundDifferential loss of striatal projection neurons in Huntington disease.
Reiner, A., Albin, R. L., Anderson, K. D., D'Amato, C. J., Penney, J. B., & Young, A. B. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5733 · Cited by 839
Hodgson, J. G., Agopyan, N., Gutekunst, C.-A., Leavitt, B. R., LePiane, F., Singaraja, R., Smith, D. J., Bissada, N., McCutcheon, K., Nasir, J., et al. (1999) · Neuron · doi:10.1016/s0896-6273(00)80764-3 · Cited by 830
Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease
Slow, E. J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg169 · Cited by 800
The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons
Wilson, C., & Kawaguchi, Y. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-07-02397.1996 · Cited by 795
Tovar, K. R., & Westbrook, G. L. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-10-04180.1999 · Cited by 786
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
DiFiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young, C., Martin, E., Vonsattel, J.-P., Carraway, R., Reeves, S. A., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90346-1 · Cited by 749
Coordinated Expression of Dopamine Receptors in Neostriatal Medium Spiny Neurons
Surmeier, D. J., Song, W.-J., & Yan, Z. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-20-06579.1996 · Cited by 747
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
Luthi-Carter, R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1259 · Cited by 720
Normal huntingtin function: an alternative approach to Huntington's disease
Cattaneo, E., Zuccato, C., & Tartari, M. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1806 · Cited by 657
Graveland, G. A., Williams, R. S., & DiFiglia, M. (1985) · Science · doi:10.1126/science.3155875 · Cited by 612
Stipe, J., White, D., & Arsdale, E. V. (1979) · The American Journal of Nursing · doi:10.2307/3424618 · Cited by 602
Zeron, M. M., Hansson, O., Chen, N., Wellington, C. L., Leavitt, B. R., Brundin, P., Hayden, M. R., & Raymond, L. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00615-3 · Cited by 595
Neurological abnormalities in a knock-in mouse model of Huntington's disease
Lin, C.-H. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.2.137 · Cited by 592
Fonnum, F., Storm-Mathisen, J., & Divac, I. (1981) · Neuroscience · doi:10.1016/0306-4522(81)90168-8 · Cited by 542
Menalled, L. B., Sison, J. D., Dragatsis, I., Zeitlin, S., & Chesselet, M. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10776 · Cited by 536
White, J. K., Auerbach, W., Duyao, M. P., Vonsattel, J.-P., Gusella, J. F., Joyner, A. L., & MacDonald, M. E. (1997) · Nature Genetics · doi:10.1038/ng1297-404 · Cited by 534
Delaying the onset of Huntington's in mice
van Dellen, A., Blakemore, C., Deacon, R., York, D., & Hannan, A. J. (2000) · Nature · doi:10.1038/35008142 · Cited by 511
Cha, J.-H. J., Kosinski, C. M., Kerner, J. A., Alsdorf, S. A., Mangiarini, L., Davies, S. W., Penney, J. B., Bates, G. P., & Young, A. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6480 · Cited by 504
Excitotoxic injury of the neostriatum: a model for Huntington's disease
DiFiglia, M. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90111-m · Cited by 471
Wheeler, V. C. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.4.503 · Cited by 469
Lapper, S. R., & Bolam, J. P. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90293-b · Cited by 451
CB1 Cannabinoid Receptor Inhibits Synaptic Release of Glutamate in Rat Dorsolateral Striatum
Gerdeman, G., & Lovinger, D. M. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.1.468 · Cited by 433
Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease
Turmaine, M., Raza, A., Mahal, A., Mangiarini, L., Bates, G. P., & Davies, S. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.110078997 · Cited by 430
Duan, W., Guo, Z., Jiang, H., Ware, M., Li, X.-J., & Mattson, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0536856100 · Cited by 428 · cited 1×
“In fact, dietary restriction (Duan et al., 2003), as well as several candidate drugs to treat HD such as cisteamine (Borrell-Pages et al.”
Backgroundde la Monte, S. M., Vonsattel, J.-P., & Richardson, E. P. (1988) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198809000-00003 · Cited by 428
Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues
Strong, T. V., Tagle, D. A., Valdes, J. M., Elmer, L. W., Boehm, K., Swaroop, M., Kaatz, K. W., Collins, F. S., & Albin, R. L. (1993) · Nature Genetics · doi:10.1038/ng1193-259 · Cited by 416
Aizman, O., Brismar, H., Uhlén, P., Zettergren, E., Levey, A. I., Forssberg, H., Greengard, P., & Aperia, A. (2000) · Nature Neuroscience · doi:10.1038/72929 · Cited by 415
Baquet, Z. C., Gorski, J. A., & Jones, K. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3920-03.2004 · Cited by 414
Replicating Huntington's disease phenotype in experimental animals
Brouillet, E. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00005-2 · Cited by 413
Regulation of F-Actin Stability in Dendritic Spines by Glutamate Receptors and Calcineurin
Halpain, S., Hipolito, A., & Saffer, L. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09835.1998 · Cited by 408 · cited 2×
“Studies of hippocampal neurons show that exposure to glutamate or NMDA for short periods of time can produce a rapid loss of dendritic spines (Halpain et al., 1998).”
BackgroundMurphy, K. P. S. J., Carter, R. J., Lione, L. A., Mangiarini, L., Mahal, A., Bates, G. P., Dunnett, S. B., & Morton, A. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-13-05115.2000 · Cited by 398
Inhibition of GABAASynaptic Responses by Brain-Derived Neurotrophic Factor (BDNF) in Rat Hippocampus
Tanaka, T., Saito, H., & Matsuki, N. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-09-02959.1997 · Cited by 385 · cited 1×
“, 1998) but decreases GABAergic currents (Tanaka et al., 1997).”
Lione, L. A., Carter, R. J., Hunt, M. J., Bates, G. P., Morton, A. J., & Dunnett, S. B. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-23-10428.1999 · Cited by 384
Loss of normal huntingtin function: new developments in Huntington's disease research
Cattaneo, E. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01721-5 · Cited by 382
Heterosynaptic Dopamine Neurotransmission Selects Sets of Corticostriatal Terminals
Bamford, N. S., Zhang, H., Schmitz, Y., Wu, N.-P., Cepeda, C., Levine, M. S., Schmauss, C., Zakharenko, S. S., Zablow, L., & Sulzer, D. (2004) · Neuron · doi:10.1016/s0896-6273(04)00265-x · Cited by 373
Self-citationGlutamine repeats and neurodegenerative diseases: molecular aspects
Perutz, M. F. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01350-4 · Cited by 359
Glutamine Repeats and Neurodegenerative Diseases: Molecular Aspects
Suchowersky, O. (2002) · Archives of Neurology · doi:10.1001/archneur.59.6.1038 · Cited by 356
Levine, M. S., Klapstein, G. J., Koppel, A., Gruen, E., Cepeda, C., Vargas, M. E., Jokel, E. S., Carpenter, E. M., Zanjani, H., Hurst, R. S., et al. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991115)58:4<515::aid-jnr5>3.0.co;2-f · Cited by 352
Self-citationMitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse
Tabrizi, S. J., Workman, J., Hart, P. E., Mangiarini, L., Mahal, A., Bates, G., Cooper, J. M., & Schapira, A. H. V. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200001)47:1<80::aid-ana13>3.0.co;2-k · Cited by 351
Dopamine and N-Methyl-D- Aspartate Receptor Interactions in the Neostriatum
Cepeda, C., & Levine, M. S. (1998) · Developmental Neuroscience · doi:10.1159/000017294 · Cited by 351
Self-citationNisenbaum, E., & Wilson, C. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-06-04449.1995 · Cited by 348
Environmental enrichment slows disease progression in R6/2 Huntington's disease mice
Hockly, E., Cordery, P. M., Woodman, B., Mahal, A., Van Dellen, A., Blakemore, C., Lewis, C. M., Hannan, A. J., & Bates, G. P. (2002) · Annals of Neurology · doi:10.1002/ana.10094 · Cited by 330
Extrasynaptic glutamate spillover in the hippocampus: evidence and implications
Kullmann, D. M., & Asztely, F. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01150-8 · Cited by 326
Kainate-induced degeneration of neostriatal neurons: dependency upon corticostriatal tract
McGeer, E. G., McGeer, P. L., & Singh, K. (1978) · Brain Research · doi:10.1016/0006-8993(78)90941-1 · Cited by 325
Cepeda, C., Hurst, R. S., Calvert, C. R., Hernández-Echeagaray, E., Nguyen, O. K., Jocoy, E., Christian, L. J., Ariano, M. A., & Levine, M. S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00961.2003 · Cited by 321
Self-citationBehrens, P. F. (2002) · Brain · doi:10.1093/brain/awf180 · Cited by 320
Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease
Hedreen, J. C., Peyser, C. E., Folstein, S. E., & Ross, C. A. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90583-f · Cited by 319
Spontaneous Activity of Neostriatal Cholinergic Interneurons In Vitro
Bennett, B. D., & Wilson, C. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-13-05586.1999 · Cited by 319
Li, Y.-X., Zhang, Y., Lester, H. A., Schuman, E. M., & Davidson, N. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-24-10231.1998 · Cited by 318
NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum
Landwehrmeyer, G., Standaert, D., Testa, C., Penney, J., & Young, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-07-05297.1995 · Cited by 317
Mouse models of Huntington's disease
Menalled, L. B., & Chesselet, M.-F. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01884-8 · Cited by 315
Klapstein, G. J., Fisher, R. S., Zanjani, H., Cepeda, C., Jokel, E. S., Chesselet, M.-F., & Levine, M. S. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.6.2667 · Cited by 314
Self-citationImpaired Glutamate Uptake in the R6 Huntington's Disease Transgenic Mice
Liévens, J.-C., Woodman, B., Mahal, A., Spasic-Boscovic, O., Samuel, D., Kerkerian-Le Goff, L., & Bates, G. P. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0430 · Cited by 313
Kemp, J. M., & Powell, T. P. S. (1971) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1971.0105 · Cited by 308
Li, H., Li, S.-H., Johnston, H., Shelbourne, P. F., & Li, X.-J. (2000) · Nature Genetics · doi:10.1038/78054 · Cited by 303
Sun, Y., Savanenin, A., Reddy, P. H., & Liu, Y. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103501200 · Cited by 297
Laforet, G. A., Sapp, E., Chase, K., McIntyre, C., Boyce, F. M., Campbell, M., Cadigan, B. A., Warzecki, L., Tagle, D. A., Reddy, P. H., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09112.2001 · Cited by 290
Self-citationSevere deficiencies in dopamine signaling in presymptomatic Huntington's disease mice
Bibb, J. A., Yan, Z., Svenningsson, P., Snyder, G. L., Pieribone, V. A., Horiuchi, A., Nairn, A. C., Messer, A., & Greengard, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120166397 · Cited by 289
Lessons from animal models of Huntington's disease
Rubinsztein, D. C. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(01)02625-7 · Cited by 283
Lei, W., Jiao, Y., Del Mar, N., & Reiner, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1990-04.2004 · Cited by 277
NMDA receptor function in mouse models of Huntington disease
Cepeda, C., Ariano, M. A., Calvert, C. R., Flores‐Hernández, J., Chandler, S. H., Leavitt, B. R., Hayden, M. R., & Levine, M. S. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1244 · Cited by 274
Self-citationOrexin loss in Huntington's disease
Petersén, Å., Gil, J., Maat-Schieman, M. L. C., Björkqvist, M., Tanila, H., Araújo, I. M., Smith, R., Popovic, N., Wierup, N., Norlén, P., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi004 · Cited by 271
Regional Specificity of Brain Atrophy in Huntington's Disease
Halliday, G. M., McRitchie, D. A., Macdonald, V., Double, K. L., Trent, R. J., & McCusker, E. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6919 · Cited by 271
Interaction of Huntingtin-Associated Protein with Dynactin P150Glued
Li, S.-H., Gutekunst, C.-A., Hersch, S. M., & Li, X.-J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-04-01261.1998 · Cited by 270
Bidirectional Activity-Dependent Plasticity at Corticostriatal Synapses
Fino, E., Glowinski, J., & Venance, L. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4476-05.2005 · Cited by 270
Pang, T. Y. C., Stam, N. C., Nithianantharajah, J., Howard, M. L., & Hannan, A. J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.04.013 · Cited by 265
Shelbourne, P. F., Killeen, N., Hevner, R. F., Johnston, H. M., Tecott, L., Lewandoski, M., Ennis, M., Ramirez, L., Li, Z., Iannicola, C., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.5.763 · Cited by 263
Bates, G. P., Murphy, K., Harper, P. S., & Jones, L. A. (2002) · Cited by 263
Synaptic input and output of parvalbumin-immunoreactive neurons in the neostriatum of the rat
Bennett, B. D., & Bolam, J. P. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90471-5 · Cited by 261
Huang, C., Lo, S., & Hsu, K. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0731e.x · Cited by 248
Distinct Roles of Synaptic and Extrasynaptic NMDA Receptors in Excitotoxicity
Sattler, R., Xiong, Z., Lu, W.-Y., MacDonald, J. F., & Tymianski, M. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00022.2000 · Cited by 247
Brünig, I., Penschuck, S., Berninger, B., Benson, J., & Fritschy, J. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01506.x · Cited by 247
Borrell-Pages, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27607 · Cited by 236
Lovinger, D. M., & McCool, B. A. (1995) · Journal of Neurophysiology · doi:10.1152/jn.1995.73.3.1076 · Cited by 234
The neostriatal mosaic: multiple levels of compartmental organization
Gerfen, C. R. (1992) · Advances in Neuroscience and Schizophrenia · doi:10.1007/978-3-7091-9211-5_4 · Cited by 232
Impaired Synaptic Plasticity in Mice Carrying the Huntington's Disease Mutation
Usdin, M. T., Shelbourne, P. F., Myers, R. M., & Madison, D. V. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.5.839 · Cited by 230
Huntington's disease: the challenge for cell biologists
Tobin, A. J., & Signer, E. R. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01853-5 · Cited by 229
Hansson, O., Petersén, Å., Leist, M., Nicotera, P., Castilho, R. F., & Brundin, P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8727 · Cited by 228
Charpier, S., & Deniau, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.7036 · Cited by 222
Landwehrmeyer, G. B., McNeil, S. M., Dure, L. S., Ge, P., Aizawa, H., Huang, Q., Ambrose, C. M., Duyao, M. P., Bird, E. D., Bonilla, E., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410370213 · Cited by 222
Gu, X., Li, C., Wei, W., Lo, V., Gong, S., Li, S.-H., Iwasato, T., Itohara, S., Li, X.-J., Mody, I., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.03.025 · Cited by 221
Menalled, L. B., Sison, J. D., Wu, Y., Olivieri, M., Li, X.-J., Li, H., Zeitlin, S., & Chesselet, M.-F. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-18-08266.2002 · Cited by 219
Popoli, P., Pintor, A., Domenici, M. R., Frank, C., Tebano, M. T., Pèzzola, A., Scarchilli, L., Quarta, D., Reggio, R., Malchiodi-Albedi, F., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01967.2002 · Cited by 218
Deng, Y. P., Albin, R. L., Penney, J. B., Young, A. B., Anderson, K. D., & Reiner, A. (2004) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2004.02.005 · Cited by 217
Can the brain be protected through exercise? Lessons from an animal model of parkinsonism☆
Smith, A. D., & Zigmond, M. J. (2003) · Experimental Neurology · doi:10.1016/j.expneurol.2003.08.017 · Cited by 209
Huntington's disease: a synaptopathy?
Li, J.-Y., Plomann, M., & Brundin, P. (2003) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.08.006 · Cited by 208
Li, H. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1227 · Cited by 206
Facilitated Glutamatergic Transmission in the Striatum of D2Dopamine Receptor-Deficient Mice
Cepeda, C., Hurst, R. S., Altemus, K. L., Flores-Hernández, J., Calvert, C. R., Jokel, E. S., Grandy, D. K., Low, M. J., Rubinstein, M., Ariano, M. A., et al. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.2.659 · Cited by 203
Self-citationMorphometric analysis of the prefrontal cortex in Huntington's disease
Sotrel, A., Paskevich, P. A., Kiely, D. K., Bird, E. D., Williams, R. S., & Myers, R. H. (1991) · Neurology · doi:10.1212/wnl.41.7.1117 · Cited by 203
Guidetti, P., Charles, V., Chen, E.-Y., Reddy, P. H., Kordower, J. H., Whetsell, W. O., Schwarcz, R., & Tagle, D. A. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7626 · Cited by 198
Degeneration of pyramidal projection neurons in Huntington's disease cortex
Cudkowicz, M., & Kowall, N. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270217 · Cited by 196
Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery
Zuccato, C., Liber, D., Ramos, C., Tarditi, A., Rigamonti, D., Tartari, M., Valenza, M., & Cattaneo, E. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2005.01.001 · Cited by 196
Fusco, F. R., Chen, Q., Lamoreaux, W. J., Figueredo-Cardenas, G., Jiao, Y., Coffman, J. A., Surmeier, D. J., Honig, M. G., Carlock, L. R., & Reiner, A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-04-01189.1999 · Cited by 191
Pérez‐Navarro, E., Canudas, A. M., Åkerud, P., Alberch, J., & Arenas, E. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752190.x · Cited by 190
Dopamine in neurotoxicity and neuroprotection: what do D2 receptors have to do with it?
Bozzi, Y., & Borrelli, E. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.01.002 · Cited by 187
Spires, T. L., Grote, H. E., Garry, S., Cordery, P. M., Van Dellen, A., Blakemore, C., & Hannan, A. J. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03374.x · Cited by 183
Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect
Levine, M. S., Cepeda, C., Hickey, M. A., Fleming, S. M., & Chesselet, M.-F. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.08.008 · Cited by 183
Self-citationThe selective vulnerability of nerve cells in Huntington's disease
Sieradzan, K. A., & Mann, D. M. A. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2001.00299.x · Cited by 180
CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model
Chou, S., Lee, Y., Chen, H., Chiang, M., Lai, H., Chang, H., Wu, Y., Sun, C., Chien, C., Lin, Y., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03029.x · Cited by 173
Sapp, E., Penney, J., Young, A., Aronin, N., Vonsattel, J.-P., & DiFiglia, M. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199902000-00006 · Cited by 171
Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease
Milnerwood, A. J., Cummings, D. M., Dallérac, G. M., Brown, J. Y., Vatsavayai, S. C., Hirst, M. C., Rezaie, P., & Murphy, K. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl092 · Cited by 171
Self-citationThe selective vulnerability of striatopallidal neurons
Mitchell, I. J., Cooper, A. J., & Griffiths, M. R. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00019-2 · Cited by 168
Synaptic dysfunction in Huntington's disease: a new perspective
Smith, R., Brundin, P., & Li, J.-Y. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5084-5 · Cited by 166
Yin, H. H., & Lovinger, D. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510797103 · Cited by 166
Berretta, S., Parthasarathy, H. B., & Graybiel, A. M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-12-04752.1997 · Cited by 164
Calabresi, P., Gubellini, P., Picconi, B., Centonze, D., Pisani, A., Bonsi, P., Greengard, P., Hipskind, R. A., Borrelli, E., & Bernardi, G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05110.2001 · Cited by 163
Ferrante, R. J., Gutekunst, C.-A., Persichetti, F., McNeil, S. M., Kowall, N. W., Gusella, J. F., MacDonald, M. E., Beal, M. F., & Hersch, S. M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-09-03052.1997 · Cited by 161
Sapp, E., Ge, P., Aizawa, H., Bird, E., Penney, J., Young, A. B., Vonsattel, J.-P., & Difiglia, M. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00427-7 · Cited by 161
Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release
Li, H., Wyman, T., Yu, Z.-X., Li, S.-H., & Li, X.-J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg218 · Cited by 157
Molecular and behavioral analysis of the r6/1 huntington′s disease transgenic mouse
Naver, B., Stub, C., Møller, M., Fenger, K., Hansen, A. K., Hasholt, L., & Sørensen, S. A. (2003) · Neuroscience · doi:10.1016/j.neuroscience.2003.08.053 · Cited by 154
Richfield, E. K., Maguire‐Zeiss, K. A., Vonkeman, H. E., & Voorn, P. (1995) · Annals of Neurology · doi:10.1002/ana.410380605 · Cited by 153
Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics
Blum, D. L., Hourez, R., Galas, M., Popoli, P., & Schiffmann, S. N. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00411-3 · Cited by 149
Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain
Ginés, S., Bosch, M., Marco, S., Gavaldà, N., Díaz-Hernández, M., Lucas, J. J., Canals, J. M., & Alberch, J. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04590.x · Cited by 147
Mizuta, I., Ohta, M., Ohta, K., Nishimura, M., Mizuta, E., & Kuno, S. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02098-5 · Cited by 145
Standaert, D. G., Friberg, I. K., Landwehrmeyer, G. B., Young, A. B., & Penney, J. B. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00293-9 · Cited by 143
Abnormalities in the synaptic vesicle fusion machinery in Huntington's disease.
Morton, A., Faull, R., & Edwardson, J. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00611-6 · Cited by 143
Morton, A. J., Lagan, M., Skepper, J. N., & Dunnett, S. B. (2000) · Journal of Neurocytology · doi:10.1023/a:1010887421592 · Cited by 138
Riluzole therapy in Huntington's disease (HD)
Rosas, H. D., Koroshetz, W. J., Jenkins, B. G., Chen, Y. I., Hayden, D. L., Beal, M. F., & Cudkowicz, M. (1999) · Movement Disorders · doi:10.1002/1531-8257(199903)14:2<326::aid-mds1019>3.0.co;2-q · Cited by 138
Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing
Hickey, M. A., GALLANT, K., GROSS, G., LEVINE, M., & Chesselet, M.-F. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.01.024 · Cited by 137
Self-citation3‐Nitropropionic Acid Toxicity in the Striatum
Wüllner, U., Young, A. B., Penney, J. B., et al. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63051772.x · Cited by 137
Where Do You Think You Are Going? The NMDA-D1 Receptor Trap
Cepeda, C., & Levine, M. S. (2006) · Science's STKE · doi:10.1126/stke.3332006pe20 · Cited by 136
Self-citationShehadeh, J., Fernandes, H. B., Mullins, M. Z., Graham, R. K., Leavitt, B. R., Hayden, M. R., & Raymond, L. A. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.001 · Cited by 136
Decrease in Striatal Enkephalin mRNA in Mouse Models of Huntington’s Disease
Menalled, L., Zanjani, H., Mackenzie, L., Koppel, A. B., Carpenter, E. M., Zeitlin, S., & Chesselet, M. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7327 · Cited by 133
Malenka, R., & Kocsis, J. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-10-03750.1988 · Cited by 131
Calabresi, P., Centonze, D., Pisani, A., Sancesario, G., Gubellini, P., Marfia, G. A., & Bernardi, G. (1998) · Annals of Neurology · doi:10.1002/ana.410430506 · Cited by 131
Pre- and postsynaptic localization of GABAB receptors in the basal ganglia in monkeys
Charara, A., Heilman, C. J., Levey, A. I., & Smith, Y. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00409-1 · Cited by 131
Huntingtin in health and disease
Young, A. B. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17742 · Cited by 131
Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease
Li, L., Fan, M., Icton, C. D., Chen, N., Leavitt, B. R., Hayden, M. R., Murphy, T. H., & Raymond, L. A. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.04.003 · Cited by 128
Schiefer, J., Landwehrmeyer, G. B., Lüesse, H., Sprünken, A., Puls, C., Milkereit, A., Milkereit, E., & Kosinski, C. M. (2002) · Movement Disorders · doi:10.1002/mds.10229 · Cited by 127
Cummings, D. M., Milnerwood, A. J., Dallérac, G. M., Waights, V., Brown, J. Y., Vatsavayai, S. C., Hirst, M. C., & Murphy, K. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl224 · Cited by 127
Self-citationPyramidal cell loss in motor cortices in Huntington's disease.
Macdonald, V., & Halliday, G. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0528 · Cited by 125
Nisenbaum, E. S., Berger, T., & Grace, A. A. (1992) · Journal of Neurophysiology · doi:10.1152/jn.1992.67.2.477 · Cited by 124
Alberch, J., Pérez‐Navarro, E., & Canals, J. M. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00775-4 · Cited by 123
The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease
Hickey, M. A., Reynolds, G. P., & Morton, A. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00804.x · Cited by 122
Dosage effects of riluzole in Huntington’s disease: A multicenter placebo-controlled study
Huntington Study Group (2003) · Neurology · doi:10.1212/01.wnl.0000096019.71649.2b · Cited by 121
Neurotrophic factors in Huntington's disease
Alberch, J., Pérez‐Navarro, E., & Canals, J. M. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)46014-7 · Cited by 119
Uhl, G. R., NAVIA, B. A., & Douglas, J. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-12-04755.1988 · Cited by 118
Increased GABAergic function in mouse models of Huntington's disease: Reversal by BDNF
Cepeda, C., Starling, A. J., Wu, N., Nguyen, O. K., Uzgil, B., Soda, T., André, V. M., Ariano, M. A., & Levine, M. S. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20344 · Cited by 118
Self-citationBlum, D. L., Galas, M., Pintor, A., Brouillet, E., Ledent, C. A., Müller, C. E., Bantubungi, K., Galluzzo, M., Gall, D., Cuvelier, L., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-12-05361.2003 · Cited by 116
Schiefer, J., Sprünken, A., Puls, C., Lüesse, H., Milkereit, A., Milkereit, E., Johann, V., & Kosinski, C. M. (2004) · Brain Research · doi:10.1016/j.brainres.2004.06.005 · Cited by 115
Hsu, K., Huang, C., Yang, C.-H., & Gean, P. (1995) · Brain Research · doi:10.1016/0006-8993(95)00734-8 · Cited by 114
Striatal Potassium Channel Dysfunction in Huntington's Disease Transgenic Mice
Ariano, M. A., Cepeda, C., Calvert, C. R., Flores‐Hernández, J., Hernández, E., Klapstein, G. J., Chandler, S. H., D, N. A. M., DiFiglia, M., & Levine, M. S. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00791.2004 · Cited by 113
Self-citationGABAB receptors at glutamatergic synapses in the rat striatum
Lacey, C. J., Boyes, J., Gerlach, O. H. H., Chen, L., Magill, P. J., & Bolam, J. P. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.07.013 · Cited by 113
Cellular factors controlling neuronal vulnerability in the brain
Calabresi, P. A., Centonze, D., & Bernardi, G. (2000) · Neurology · doi:10.1212/wnl.55.9.1249 · Cited by 111
Effects of cortical ablation on the neurotoxicity and receptor binding of kainic acid in striatum
Bizière, K., & Coyle, J. T. (1979) · Journal of Neuroscience Research · doi:10.1002/jnr.490040507 · Cited by 111
Li, L., Murphy, T. H., Hayden, M. R., & Raymond, L. A. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00308.2004 · Cited by 106
Carter, R. J., Hunt, M. J., & Morton, A. J. (2000) · Movement Disorders · doi:10.1002/1531-8257(200009)15:5<925::aid-mds1025>3.0.co;2-z · Cited by 106
McCaw, E. A., Hu, H., Gomez, G. T., Hebb, A. L. O., Kelly, M. E. M., & Denovan‐Wright, E. M. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04460.x · Cited by 106
A controlled clinical trial of baclofen as protective therapy in early huntington's disease
Shoulson, I., Odoroff, C. L., Oakes, D., Behr, J., Goldblatt, D., Caine, E. D., Kennedy, J., Miller, C., Bamford, K. A., Rubin, A., et al. (1989) · Annals of Neurology · doi:10.1002/ana.410250308 · Cited by 106
Progressive depletion of complexin II in a transgenic mouse model of Huntington's disease
Morton, A., & Edwardson, J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00059.x · Cited by 104
Lastres‐Becker, I., Berrendero, F., Lucas, J. J., Martı́n-Aparicio, E., Yamamoto, A., Ramos, J. A., & Fernández‐Ruíz, J. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03403-5 · Cited by 103
Corticostriatal plasticity: life after the depression
Mahon, S., Deniau, J., & Charpier, S. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.06.010 · Cited by 100
Starling, A. J., André, V. M., Cepeda, C., de Lima, M., Chandler, S. H., & Levine, M. S. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20651 · Cited by 99
Self-citationStriatal neurochemical changes in transgenic models of Huntington's disease
Ariano, M. A., D, N. A. M., DiFiglia, M., Tagle, D. A., Sibley, D. R., Leavitt, B. R., Hayden, M. R., & Levine, M. S. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10272 · Cited by 96
Self-citationNicNiocaill, B., Haraldsson, B., Hansson, O., O'Connor, W. T., & Brundin, P. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2000.01379.x · Cited by 94
Dendritic spines for neuroprotection: a hypothesis
Segal, M. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)92765-i · Cited by 93
Díaz-Hernández, M., Torres-Peraza, J. F., Salvatori-Abarca, A., Morán, M. A., Gómez‐Ramos, P., Alberch, J., & Lucas, J. J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3183-05.2005 · Cited by 90
Picconi, B., Passino, E., Sgobio, C., Bonsi, P., Barone, I., Ghiglieri, V., Pisani, A., Bernardi, G., Ammassari‐Teule, M., & Calabresi, P. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.10.009 · Cited by 90
Mouse Models of Huntington’s Disease
Farshim, P. P., & Bates, G. P. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7825-0_6 · Cited by 89
Tarditi, A., Camurri, A., Varani, K., Borea, P. A., Woodman, B., Bates, G. P., Cattaneo, E. F., & Abbracchio, M. P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.014 · Cited by 89
Huntington Disease in Children: Genotype-Phenotype Correlation
Rasmussen, A., Macias, R., Yescas, P., Ochoa, A., Davila, G., & Alonso, E. (2000) · Neuropediatrics · doi:10.1055/s-2000-7461 · Cited by 89
Huntington'S disease: Treatment with muscimol, A GABA‐mimetic drug
Shoulson, I., Goldblatt, D., Charlton, M. H., & Joynt, R. J. (1978) · Annals of Neurology · doi:10.1002/ana.410040316 · Cited by 88
Rebec, G., Conroy, S. K., & Barton, S. J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.08.062 · Cited by 86
Dopamine selects glutamatergic inputs to neostriatal neurons
Flores‐Hernández, J., Galarraga, E., & Bargas, J. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199702)25:2<185::aid-syn9>3.0.co;2-8 · Cited by 86
Liévens, J.-C., Woodman, B., Mahal, A., & Bates, G. P. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1152 · Cited by 85
Wood, J. D., Macmillan, J., Harper, P. S., Lowenstein, P. R., & Jones, A. L. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.4.481 · Cited by 85
A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia.
Quinn, N. P., & MARSDEN, C. D. (1984) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.47.8.844 · Cited by 84
Lozovaya, N., Kopanitsa, M. V., Boychuk, Y. A., & Krishtal, O. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00638-1 · Cited by 80
Striatal degeneration induced by mitochondrial blockade is prevented by biologically delivered NGF
Frim, D. M., Simpson, J., Uhler, T. A., Short, M. P., Bossi, S. R., Breakefield, X. O., & Ole Isacson, A. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490350413 · Cited by 80
Bi-directional changes in synaptic plasticity induced at corticostriatal synapses in vitro
Spencer, J. P., & Murphy, K. (2000) · Experimental Brain Research · doi:10.1007/s002210000523 · Cited by 78
Altered Cortical Glutamate Receptor Function in the R6/2 Model of Huntington's Disease
André, V. M., Cepeda, C., Venegas, Á., Gomez, Y., & Levine, M. S. (2005) · Journal of Neurophysiology · doi:10.1152/jn.01118.2005 · Cited by 78
Self-citationCentonze, D., Rossi, S., Prosperetti, C., Tscherter, A., Bernardi, G., Maccarrone, M., & Calabresi, P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.008 · Cited by 77
Properties of a presynaptic metabotropic glutamate receptor in rat neostriatal slices
Lovinger, D. M., Tyler, E., Fidler, S., & Merritt, A. (1993) · Journal of Neurophysiology · doi:10.1152/jn.1993.69.4.1236 · Cited by 75
Blum, D. L., Gall, D., Galas, M., d’Alcantara, P., Bantubungi, K., & Schiffmann, S. N. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-20-09122.2002 · Cited by 73
Lastres‐Becker, I., Bizat, N., Boyer, F., Hantraye, P., Brouillet, E., & Fernández‐Ruíz, J. (2003) · Neuroreport · doi:10.1097/00001756-200305060-00007 · Cited by 69
The use of transgenic and knock-in mice to study Huntington’s disease
Hickey, M. A., & Chesselet, M.-F. (2003) · Cytogenetic and Genome Research · doi:10.1159/000072863 · Cited by 69
Plotkin, J. L., Wu, N., Chesselet, M., & Levine, M. S. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04303.x · Cited by 67
Self-citation
Cited by
Striatal Plasticity and Basal Ganglia Circuit Function
Kreitzer, A. C., & Malenka, R. C. (2008) · Neuron · doi:10.1016/j.neuron.2008.11.005 · Cited by 1,017
Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
Zuccato, C., Valenza, M., & Cattaneo, E. (2010) · Physiological Reviews · doi:10.1152/physrev.00041.2009 · Cited by 848
Corticostriatal connectivity and its role in disease
Shepherd, G. M. G. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3469 · Cited by 824
Saxena, S., & Caroni, P. (2011) · Neuron · doi:10.1016/j.neuron.2011.06.031 · Cited by 572
Milnerwood, A. J., Gladding, C. M., Pouladi, M. A., Kaufman, A. M., Hines, R. M., Boyd, J. D., Ko, R. W. Y., Vasuta, O. C., Graham, R. K., Hayden, M. R., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.008 · Cited by 517
Metadata
- Authors
- CEPEDA, C., WU, N., ANDRE, V, CUMMINGS, D., & LEVINE, M.
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 81
- Issue
- 5-6
- Pages
- 253-271
- ISSN
- 0301-0082 (ISSN-L)
- OpenAlex
- W1973765221
- Cited by
- 310
- References
- 233
- FWCI
- 5.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.